Trial · NCT07886723
Photobiomodulation After Nonsurgical Root Canal Treatment
NCT07886723, Not applicable, Not yet recruiting, University of Minnesota
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Photobiomodulation After Nonsurgical Root Canal Treatment. Trials, record NCT07886723. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07886723
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Photobiomodulation After Nonsurgical Root Canal Treatment
- NCT number
- NCT07886723
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 60 participants, estimated
- Lead sponsor
- University of Minnesota
- Conditions
- Symptomatic Apical Periodontitis, Postoperative Pain, Mechanical Allodynia
- Interventions
- Adjunctive Photobiomodulation, Sham Photobiomodulation
- First posted
- 2026-10-21
- Last updated
- 2026-10-21
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Mechanical Allodynia Measured by Maximum Occlusal Force Difference | Baseline | Mechanical allodynia will be evaluated by measuring maximum occlusal force on the treated tooth and the corresponding contralateral asymptomatic tooth. The primary endpoint is the change in the difference in maximum occlusal force between the treated and contralateral teeth from baseline to follow-up. |
| Primary | Change in Mechanical Allodynia Measured by Maximum Occlusal Force Difference | 2 days after treatment | Mechanical allodynia will be evaluated by measuring maximum occlusal force on the treated tooth and the corresponding contralateral asymptomatic tooth. The primary endpoint is the change in the difference in maximum occlusal force between the treated and contralateral teeth from baseline to follow-up. |
| Primary | Change in Mechanical Allodynia Measured by Maximum Occlusal Force Difference | 7 to 10 days after treatment | Mechanical allodynia will be evaluated by measuring maximum occlusal force on the treated tooth and the corresponding contralateral asymptomatic tooth. The primary endpoint is the change in the difference in maximum occlusal force between the treated and contralateral teeth from baseline to follow-up. |
| Secondary | Change in Postoperative Pain Measured by Numeric Rating Scale | Baseline | Postoperative pain will be assessed using the 11-point Numeric Rating Scale in response to percussion testing of the treated tooth. The secondary endpoint is the change in Numeric Rating Scale pain score from baseline to follow-up. |
| Secondary | Change in Postoperative Pain Measured by Numeric Rating Scale | 2 days after treatment | Postoperative pain will be assessed using the 11-point Numeric Rating Scale in response to percussion testing of the treated tooth. The secondary endpoint is the change in Numeric Rating Scale pain score from baseline to follow-up. |
| Secondary | Change in Postoperative Pain Measured by Numeric Rating Scale | 7 to 10 days after treatment | Postoperative pain will be assessed using the 11-point Numeric Rating Scale in response to percussion testing of the treated tooth. The secondary endpoint is the change in Numeric Rating Scale pain score from baseline to follow-up. |
| Other | Adverse Events and Treatment-Related Complications | Treatment visit through 7 to 10 days after treatment | Participants will be evaluated for adverse events or complications related to nonsurgical root canal treatment, maximum occlusal force measurement, photobiomodulation, or simulated laser treatment. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07886723
GET https://conductscience.org/api/trials/v1/NCT07886723/registered